KOL Engagement, Communication & Dissemination

Summary
Engagement, communication & dissemination of recent development and progress on ATXA’s lead drug NTP42 including with key opinion leaders (KOLs) and other stakeholders of relevance to pulmonary arterial hypertension (PAH).
More information & hyperlinks
Web resources: https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e5db138510&appId=PPGMS
Search
Search on Google
Search on Bing
Search on DuckDuckGo
Associated projects
Organisations
  • Not specified
Powered by Chris Decubber BV